BioSpace News Archive

Protech Home Medical Corp., a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced its fourth quarter and audited full year fiscal 2020 financial results and operational highlights for the period ended September 30, 2020.

The Choroideremia Research Foundation (CRF) is pleased to announce funding for its first research study in 2021 to Mariya Moosajee, MBBS, BsC (Hons), PhD, FRCOphth.

Neogen Corporation (NASDAQ: NEOG) announced today that it has relaunched its popular ThyroKare™ (levothyroxine sodium tablets), USP, which are approved by the FDA for replacement therapy for diminished thyroid function in dogs.

University of Memphis integrates Movendo Technology’s robotic system hunova© into baseline screening and physical rehabilitation of their student athletes.

Chiesi, an international research-focused Healthcare group (Chiesi Group), announces that the European Commission has granted the marketing authorization for Chiesi extrafine triple therapy combination ICS/LABA/LAMA in a single inhaler, for the treatment of asthma.

SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced the enrollment of the first patient in the company’s RESET-RA study.

Olympus Corporation announced the launch of a new comprehensive educational platform designed to provide healthcare professionals all over the world with learning opportunities and training to put their skills into practice and keep them performing at their best.

Innova Medical Group, Inc., the world’s largest manufacturer of rapid antigen test kits and leader in COVID-19 testing solutions globally, confirmed today that the company’s SARS-CoV-2 Antigen Test kits have successfully detected the several mutated strains that have become more widespread around the world in recent weeks.

Cynosure announced that Kellie Teal-Guess will join its Executive Leadership Team as the new Chief Human Resources Officer, effective immediately.

Now Offers Commercially Insured Patients $0 Copay and Free Home Delivery for Acute and Preventive Migraine Treatment Options